Stay updated with breaking news from Respiratory Interventions. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Delivers on commitments with strong growth in Core Spine, Cardiac Surgery, Structural Heart, Cardiac Pacing, and across many international markets; Diabetes increases double digits as U.S. business...
Medtronic announced today that it will exit what it describes as its increasingly unprofitable ventilator product line.
Medtronic reports Q3 2024 sales of $8.1 billion, driven by major product approvals in diabetes, cardiac rhythm management, and more. Medtronic's move to exit the ventilator product line.
MDT earnings call for the period ending December 31, 2023.
Bob White, the EVP and president of Medtronic's Medical Surgical portfolio, will be leaving the company due to a new round of reorganization.